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Abstract
hrysin and its phosphate ester have previously been shown to inhibit cell proliferation and induce apoptosis in Hela cells;
however, the underlying mechanism remains to be characterized. In the present study, we therefore synthesized diethyl
flavon-7-yl phosphate (FP, C19H19O6P) by a simplified Atheron-Todd reaction, and explored its anti-tumor characteristics and
mechanisms. Cell proliferation, cell cycle progression and apoptosis were measured by MTS, flow cytometry and terminal
deoxynucleotidyl transferase dUTP nick end labeling techniques, respectively in human cervical cancer HeLa cells treated
with 7-hydroxyflavone (HF) and FP. p21, proliferating cell nuclear antigen (PCNA) and cAMP levels in Hela cells were
analyzed by western blot and radioimmunoassay. Both HF and FP inhibited proliferation and induced apoptosis in HeLa
cells via induction of PCNA/p21 expression, cleaved caspase-3/poly (ADP-ribose) polymerase (PARP)-1, elevation of cAMP
levels, and cell cycle arrest with accumulation of cells in the G0/G1 fraction. The effects of FP were more potent than those
of HF. The interactions of FP with Ca
2+-calmodulin (CaM) and Ca
2+-CaM-phosphodiesterase (PDE)1 were explored by
electrospray ionization-mass spectrometry and fluorescence spectra. FP, but not HF, formed non-covalent complexes with
Ca
2+-CaM-PDE1, indicating that FP is an inhibitor of PDE1, and resulting in elevated cellular cAMP levels. It is possible that
the elevated cAMP levels inhibit growth and induce apoptosis in Hela cells through induction of p21 and cleaved caspase-3/
PARP-1 expression, and causing down-regulation of PCNA and cell cycle arrest with accumulation of cells in the G0/G1 and
G2/M fractions. In conclusion, FP was shown to be a Ca
2+-CaM-PDE inhibitor, which might account for its underlying anti-
cancer mechanism in HeLa cells. These observations clearly demonstrate the special roles of phosphorylated flavonoids in
biological processes, and suggest that FP might represent a potential new drug for the therapy of human cervical
carcinoma.
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Introduction
Among the variety of natural products, flavonoids have always
attracted considerable interest because of their potential beneficial
effects on human health and their widespread availability in fruits,
vegetables, herbs and some beverages [1,2]. Most flavonoids have
demonstrated anti-tumor properties including anti-proliferation,
cell cycle arrest in G0/G1 or G2/M, and induction of
differentiation and apoptosis in various cell lines [3–5].
A large number of phosphorus compounds possess P-O bond(s)
as phosphate esters (e.g., DNA, RNA, ATP, phospholipids, etc.)
and these esters of phosphoric acid play a vital role in many
biological processes [6,7]. They appear to be synthesized and
undergo interconversion with great ease in living organisms [8].
Our previous studies showed that phosphorylated flavonoids
possess relatively stronger binding affinities towards proteins such
as myoglobin, insulin, and lysozyme and more easily form non-
covalent compounds with them, compared to non-phosphorylated
forms [9,10]. As part of a screening program, we previously
reported that phosphorylated chrysin did indeed exhibit stronger
activity against HeLa tumor cells in vitro than non-phosphorylated
chrysin [11]. These positive biomedical effects are mostly
attributed to the potential of flavonoids to act as esters of
phosphoric acid, but the underlying mechanism remains unclear.
To explore these mechanisms, the phosphate ester (FP,
C19H19O6P) of 7-hydroxyflavone (HF) was synthesized via a
simplified Atheron-Todd reaction. It is an established fact that
biochemical activities depend on the individual structure, and each
compound needs to be studied systematically to assess its
individual biological potency. In this study, we explored the
anti-tumor characteristics of HF/FP with only one hydroxyl/
phosphorylated structure in the flavone subgroup. The effects of
these compounds on proliferation and apoptosis in HeLa cells
could thus be assessed and compared.
MTS, flow cytometry, proliferating cell nuclear antigen (PCNA)
immunohistochemistry and terminal deoxynucleotidyl transferase
dUTP nick end labeling (TUNEL) techniques were used to gain an
insight into the mechanisms of growth inhibition, cell proliferation,
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Ccell cycle progression, and apoptosis, respectively. Apoptosis was
also determined by FACScanto II analysis. Semi-quantitative
western immunoblotting was performed to assess the effects of
HF/FP on protein expression levels. Alterations in cAMP levels
were measured by radioimmunoassay (RIA). In addition, Ca
2+-
CaM-PDE complex inhibition was analyzed in vitro to provide
detailed information about the possible mechanisms responsible
for the anti-cancer activities. Moreover, we investigated the
interactions between HF and FP, and the Ca
2+-CaM-PDE
enzyme system using fluorescence spectrometry to gain evidence
for this mechanism in living systems. The results of this study may
have important implications for the use of FP as a potent new
agent for cancer prevention, as well as for other pharmacological
and toxicological uses.
Results
Growth inhibitory effects of FP and HF in Hela cells
Cell growth was inhibited by 5, 10, 20, 40, 60 or 80 mM HF and
FP for 24 or 72 h in dose-dependent manners (Figure 1 A and B).
The estimated IC50 values at 24 h were 51.9 mM for HF and
48.2 mM for FP, and those at 72 h were 32.1 mM for HF and
18.5 mM for FP. Cultured human HeLa cells were treated with HF
and FP at concentrations of 20 and 40 mM for 24, 48, 72 and 96 h.
HF and FP caused marked reductions in cell viability in time-
dependent manners, compared to the control group, as shown by
MTS assay. FP had a more potent effect on cell viability than HF.
Effects of FP and HF on cell cycle distribution
Cell cycle analysis using propidium iodide (PI) staining and flow
cytometry was used to determine the effects of HF and FP on cell
cycle perturbation. The cell cycle distributions of HeLa cells
treated with FP and HF 10, 20, 40 and 80 mM at various time
points are shown in Figure 2. Both FP (Figure 2A) and HF
(Figure 2B) significantly altered cell cycle progression. They
induced cell-growth arrest in HeLa cells in a dose-dependent
fashion at 24 h, and 20 mM FP and HF also arrested the cell cycle
in time-dependent manners, compared to the control group
(Figure 2 C, D and E). As shown in Figure 2D, .40 mMF Po r
80 mM HF significantly increased the percentage of HeLa cells in
G1 phase, accompanied by a decrease in the population in S
phase, compared to the control group, suggesting that the cell
cycle was arrested at G0/G1 phase. There was a significant
increase in the cell population in G2/M phase (Figure 2 D and E)
following treatment with FP, as well as a marked increase in the
population in G0/G1 phase and a compensatory decrease in the
population in S phase. These data suggest that HF induces cell
cycle arrest in G0/G1 phase, while FP induces cell cycle arrest in
both G0/G1 and G2/M phases.
FP- and HF-induced apoptosis
The TUNEL signal, as an apoptosis marker, appeared as a
bluish-violet color, while the denser nuclei frequently moved
towards the cell periphery. The percentage of apoptotic cells (% of
apoptosis) in the control group was 7%, and this was increased to
22% in the HF group and up to 38% in the FP group after 48 h.
There were a significant differences in apoptosis between the
treated and control groups (p,0.05), as seen in Figure 3A and C.
These results indicate that both FP and HF are potent inducers of
apoptosis, but the effect of FP is stronger than that of HF.
To determine if cell death was accompanied by the develop-
ment of an apoptotic or necrotic process, we further analyzed and
quantified the phenotypic changes in apoptotic cells by double
staining HeLa cells with Annexin V-FITC and PI. Cell apoptosis
increased significantly after treatment with 10, 20, 40 and 80 mM
FP/HF for various durations, compared to the control group
(Figure 3B, D and E). After treatment for 24 h, .40 mM FP could
increase cell apoptosis, and 80 mM FP indirectly resulted in 89%
apoptosis, whereas 80 mM HF only induced 12% apoptosis. In
cells treated with 20 mM FP or HF for 48, 72 and 96 h, apoptosis
induction was increased at 72 h, suggesting later stages of
apoptosis in culture (Figure 3B and E). As expected, cell death
in the control group remained below 7%. These results are
consistent with the results of the TUNEL method, further showing
that HF and FP could induce apoptotic cell death in cervical
cancer cells.
Effects of FP and HF on expression of PCNA in Hela cells
PCNA immunoreactivity (IR), represented by brownish-colored
granules, was located mainly in the nuclei. Inactivated PCNA was
located primarily in the cytoplasm, and translocated to the nuclei
once activated. PCNA-IR intensities evaluated as the integration
value (IV) after 48 h were 308 in the FP group and 348 in the HF
group, which were significantly higher than the control group
(512) (p,0.05) (Figure 4). These results further showed that FP
inhibited proliferation more intensively than HF, as demonstrated
by the PCNA expression signal intensity in HeLa cells.
Effects of FP and HF on expression of p21/Waf1, caspase-
3 and poly (ADP-ribose) polymerase (PARP)
To determine the mechanisms responsible for cell cycle arrest
and apoptosis by HF/FP, the protein expression levels of p21/
Waf1 (a cyclin-dependent kinase (CDK) inhibitor), and the
apoptosis-related proteins cleaved caspase-3 and PARP-1 were
examined using western blotting analyses. The expression levels of
p21/Waf1 in the FP group were markedly increased in a time-
dependent fashion, compared to the control group (Figure 5A and
B), with more prominent expression after 48 h than after 24 h.
p21/Waf1 expression in the FP group started to increase at 24 h,
and became especially obvious at 48 h, whereas its expression in
the HF group did not become apparent until 48 h, compared to
the control group. Changes in p21/Waf1 expression in the FP
treatment group were more marked (7-fold) in Hela cells,
compared to that in the HF treatment group during the same
period. This suggests that the up-regulation of p21/Waf1 might be
related to the cell cycle arrest induced by HF and FP.
Levels of the apoptotic proteins, cleaved PARP-1 (90 kD) and
caspase-3 (19 kD), were significantly elevated in FP- and HF-
cultured cells, compared to untreated control cells (Figure 5 C and
D). Cleaved caspase-3 started to increase at 24 h after FP
treatment, and became especially obvious at 48 h and 72 h.
While cleaved PARP-1 started to increase at 48 h after FP
treatment, and became especially obvious at 72 h. In contrast,
cleaved caspase-3 and PARP-1 became apparent after 72 h in the
HF group. There were significant differences in cleaved- caspase
3/PARP-1 between the FP and HF groups. These results suggest
that FP and HF induced HeLa cell injury or death by activating an
apoptotic pathway involving impaired nuclear function and
cellular homeostasis.
Effects of FP and HF on cAMP concentrations in Hela cells
and PDE inhibition activity in vitro
Hela cells were pre-incubated in medium for 24 h and then
incubated with 20 mMH Fo rF Pa t3 7 uC for a further 12 or 24 h.
The concentrations of cAMP in the cells were measured in the
various experimental groups (Figure 6A). The cAMP concentra-
tions were significantly increased to 12.260.67 pmol for HF and
Inhibition Effect and Mechanism of FP in HeLa Cell
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24.661.68 (FP) pmol at 24 h, compared to control cells
(9.160.78 pmol). These results represent increases of 134% and
178% at 12 h, and 167% and 270% at 24 h, respectively, which
were significantly different from the levels in control cells (p,0.05,
p,0.01). FP had a more significant effect on cAMP concentrations
than HF.
Both HF and FP inhibited the activation of PDE or CaM-
activated PDE1 from bovine brain in concentration-dependent
manners (Figure 6 B, C and D). FP inhibited PDE over a 5–
100 mM concentration range. CaM-activated PDE1 was prefer-
entially inhibited with an IC50 value of 22.3 mM, which was
significantly (two-fold) lower than the IC50 (43.5 mM) necessary for
inhibition of basal PDE1, indicating that FP could also interact
with CaM. In contrast, HF displayed lower inhibitory activities
against both basal PDE and CaM-activated PDE, with IC50 values
of 89.6 and 76.7 mM, respectively.
Stoichiometry of FP and CaM of ESI-MS
Figure 7 shows the electrospray ionization (ESI) spectrum
obtained from a mixed solution of CaM-Ca
2+ and FP. The CaM
charge-state distribution comprised several charge states ranging
from 16
+ to 10
+, with 14
+ being the most intense. The CaM mass
derived from these peaks 1052.2 (CaM+16H)
16+, 1120.0
(CaM+15H)
15+, 1199.9 (CaM+14H)
14+, 1292.1 (CaM+13H)
13+,
1399.7 (CaM+12H)
12+, 1536.8 (CaM+11H)
11+ and 1679.5
(CaM+10H)
10+ was 16,784 kD. Besides the expected multiple
protonated molecule ions, the mass spectrum revealed several
groups of new protonated ions, corresponding to several kinds of
highly charged multiple adducts, e.g., ions at m/z 1147.5, 1229.4,
1323.9, 1434.2, and 1564.5, corresponding to (Ca
2+-CaM+FP)
15+,
(Ca
2+-CaM+FP)
14+, (Ca
2+-CaM+FP)
13+, (Ca
2+-CaM+FP)
12+ and
(Ca
2+-CaM+FP)
11+. The CaM+Ca
2++FP mass derived from these
peaks was 17,198 kD (16,784+40+374). For comparison, 0.4 mM
HF was also mixed with 0.04 mM CaM-Ca
2+ and infused to ESI,
but no corresponding noncovalent CaM+Ca
2++FP complex was
detected, despite the use of various parameters. The results of
these experiments indicate that FP (phosphorylated HF) was able
to form a noncovalent complex with CaM+Ca
2+ more easily than
nonphosphorylated HF, suggesting that phosphorylation of esters
of HF could enhance their interaction with proteins.
Effects of FP on emission spectra of CaM-Ca2+-PDE
system
The interaction between CaM and FP is shown in Figure 8A.
When the FP concentration was increased, the emission peak of
Figure 1. Effects of test compounds on cell growth inhibition. A) Effects of test compounds at different concentrations on HeLa cells
following treatment for 24 h. IC50 values for FP and HF at 24 h were 46.8 and 56.9 mM, respectively. B) Effects of test compounds at different
concentrations on HeLa cells following treatment for 72 h. IC50 values for FP and HF at 72 h were 18.5 and 32.1 mM, respectively. C) Effects of 20 mM
HF and FP on cell viability following treatment for 24, 48, 72 and 96 h. D) Effects of 40 mM HF and FP on cell viability following treatment for 24, 48, 72
and 96 h. All data points represent mean 6 SEM values.
doi:10.1371/journal.pone.0036652.g001
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wavelength increased from 330 to 350 nm.
The interaction between PDE and FP is shown in Figure 8B.
The emission peak of PDE also decreased, accompanied by an
increase in FP concentration, while the maximum emission
wavelength increased from 335 to 360 nm. When equal concen-
trations of CaM and PDE were mixed with Ca
2+, the emission
intensity of the CaM-Ca
2+-PDE system (l=344 nm) increased
significantly from 400 to 3,400 (Figure 8C), indicating that the
CaM-Ca
2+-PDE enzyme system exhibited a strong intermolecular
interaction. Figure 8D shows the emission spectra of the CaM-
Ca
2+-PDE system with increasing concentrations of FP; the
emission intensity apparently decreased as the FP concentration
increased, and the maximum emission wavelength increased
Figure 2. Effects of FP/HF on cell cycle distribution. HeLa cells were treated with different concentrations of FP/HF for 24, 48, 72 and 96 h. Cells
were harvested and stained with propidium iodide. Cell cycle distribution was analyzed using a BD FACSCanto II flow cytometer. The distributions of
cells in G0/G1, S, and G2/M phases were determined using Modfit software. A) Representative cell cycle distributions after treatment with FP at 10, 20,
40 and 80 mM for 24 h. B) Representative cell cycle distributions after treatment with HF at 10, 20, 40 and 80 mM for 24 h. C) Representative cell cycle
distributions after treatment with 20 mM FP/HF at 72 h and control at 24 and 72 h. D) G0/G1, S and G2/M population percentages in each group
following treatment with 10, 20, 40 and 80 mM HF or FP for 24 h. E) G0/G1, S and G2/M population percentages in each group following treatment
with 20 mM HF or FP and control group for 24, 48, 72 and 96 h.
doi:10.1371/journal.pone.0036652.g002
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emission intensity of the CaM-Ca
2+-PDE system decreased slightly
as the HF concentration increased. According to the classical
Stern-Volmer equation [12]:
F0=F~1zKq Q ½ 
where F0 is the emission intensity in the absence of quencher, F is
the emission intensity in the presence of quencher, Kq is the
quenching constant and [Q] is the quencher concentration. The
shape of the Stern-Volmer plots can be used to characterize the
quenching as either predominantly dynamic or static. Plots of F0/
F versus [Q] appear to be linear and Kq depends on temperature.
The emission quenching on addition of FP to the CaM-Ca
2+-PDE
Figure 3. Effects of FP/HF on cell apoptosis. A) TUNEL staining for apoptosis in HeLa cells after treatment for 48 h in control, FP and HF groups;
methyl green counter-stained, 1,0006. Control group, few apoptotic cells were found; FP group, more apoptotic cells were found. B) Quantitative
analysis of apoptotic cells using Annexin V-FITC/PI double staining in exponentially growing HeLa cells. C) Apoptosis percentages in the different
groups detected using the TUNEL method at 24, 48 and 72 h. D) Apoptosis percentages (upper right (UR)+lower right (LR)) in each group following
treatment with 10, 20, 40 and 80 mM HF or FP detected by flow cytometry at 24 h. E) Apoptosis percentages (UR+LR) in each group analyzed by flow
cytometry at 24, 48, 72 and 96 h. Flow cytometry was performed on 5610
5 cells and the percentages of apoptotic, live, and dead cells were
measured. Upper left (UL; Annexin V-FITC
2/PI
+) represents dead cells, upper right (UR; Annexin V-FITC
+/PI
+) represents late apoptotic plus necrotic
cells, lower left (LL; Annexin V-FITC
2/PI
2) represents live cells, and lower right (LR; Annexin V-FITC
+/PI
2) represents early apoptotic cells. Data are
given as means 6 SD and are representative of three separate experiments. *p,0.01 versus control cells; #p,0.01 versus HF group;
$p,0.01 versus
24 h FP group.
doi:10.1371/journal.pone.0036652.g003
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integration values (IV) of each group after treatment for 24, 48 and 72 h were analyzed as described in Materials and Methods. B) PCNA-IR was
localized in the nuclei in the control group. C) PCNA-IR was attenuated in the FP group. D) PCNA-IR was attenuated and inactive PCNA-IR was also
located in the cytoplasm in the HF group. Values are given as means 6 SE. *p,0.001 versus control cells; #p,0.01 versus HF group;
$p,0.01 versus
24 h FP group.
doi:10.1371/journal.pone.0036652.g004
Figure 5. Effects of HF and FP on p21, caspase-3, and PARP in Hela cells by western blotting analyses. A) Histogram representing p21. B)
Representative western blots of p21/Waf1 in FP, HF and control groups after 24 and 48 h. C) Histogram representing cleaved caspase-3 (19 kD) and
cleaved PARP-1 (90 kD). D) Representative western blots of cleaved caspase-3 and cleaved PARP-I in the FP, HF and control groups after 24, 48 and
72 h. Total extracts obtained from HeLa cells without HF or FP treatment (Con), with 20 mM HF treatment (HF) and with 20 mM FP treatment (FP) were
subjected to western blot analysis as described in Materials and Methods. The densitometry measurements represent the amount of p21, caspase 3,
and PARP1 relative to b-actin and are given as means from triplicate experiments expressed as % of b-actin 6 SE. b-actin was used as a loading
control. *p,0.001 versus control cells; #p,0.01 versus control group;
$p,0.01 versus FP group;
&p,0.01 versus HF group.
doi:10.1371/journal.pone.0036652.g005
Inhibition Effect and Mechanism of FP in HeLa Cell
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and 37uC, respectively, are shown in Figure 9A. The experiments
demonstrated that a higher temperature was associated with a
lower the slope of the quenching curve for the CaM-Ca
2+-PDE
system in presence of different amounts of FP. The combination of
FP with CaM-Ca
2+-PDE was a single static quenching process.
The quenching data were therefore analyzed according to the
equations
F0{F ðÞ
{1~F0
{1zK{1F0
{1 Q ½ 
{1
Line weaver-Burk plots are shown in Figure 9B. The linearly-
dependent coefficients were 0.99 and 0.998. According to this
equation, the binding constants at different temperatures could be
calculated as k37uC=4.8610
4 L/mol, k25uC=6.24610
4 L/mol,
respectively. These results showed that FP, but not HF, formed
noncovalent complexes and showed high binding affinity with
CaM-Ca
2+-PDE.
Discussion
Most nontoxic dietary flavonoids are known to behave as
general cell growth inhibitors in many kinds of cultured human
cancer cell lines [13,14]. Many flavonoids can perturb cell cycle
progression and induce G1 or G2/M cell cycle arrest, which is a
fundamental activity in the process of cell proliferation [15,16].
The present results demonstrated that both HF and FP were able
to significantly inhibit proliferation in human cervical cancer
HeLa cells in dose- and time-dependent manners, with FP (IC50
value, 18.5 mM at 72 h) having a much greater effect than HF
(IC50 value, 32.1 mM at 72 h). The present study also demon-
strated a novel characteristic of FP in terms of the cell cycle, by
observing that cell populations showed greatly decreased S phases
and increased G0/G1 and G2/M phases compared to controls,
indicating that FP controlled cell cycle progression at both the G1/
S and G2/M check-point transitions, whereas HF only arrested
cell cycle progression at the G1/S check-point. The dose- and
time-dependent effects on the cell cycle could contribute to the
anti-proliferative effects of FP and HF.
Cell cycle arrest can lead to induction of apoptosis, and agents
that modulate apoptosis affect the steady-state cell population,
Figure 6. cAMP levels in Hela cells in each group and PDE inhibition activities in vitro. A) cAMP concentrations in Hela cells in each group
at 12 and 24 h. CON, control; HF, 20 mM HF group; FP, 20 mM FP group. B) Histogram representing inhibitory effects of FP and HP on PDE and CaM-
activated PDE1 activity. C) Inhibitory effects of FP and HP on CaM-activated PDE1 activity. D) Inhibitory effects of FP and HP on PDE activity from
bovine brain. Values are given as mean 6 SE; RLU (relative light units) on the y axes of panels C and D is positively related with CaM-activated PDE1 or
PDE activities. The IC50 was calculated by using a sigmoidal dose-response (variable slope) equation analysis.
&p,0.01 versus control group; *p,0.001
versus HF group;
#p,0.01 versus control group;
$p,0.01 versus 24 h FP group.
doi:10.1371/journal.pone.0036652.g006
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cancer therapy [17]. TUNEL labeling detected cells with typical
apoptotic features after HF and FP treatment. The phenotypic
changes characteristic of apoptosis were confirmed by cytometric
analysis using double staining with FITC-Annexin V and PI. The
levels of apoptosis induced by HF (,80 mM) or FP (,40 mM)
treatment for 24 h indicated that HF mainly arrested cell cycle
progression, not apoptosis, while FP arrested the cell cycle and
induced apoptosis even in the early stages. The levels of apoptosis
after treatment with 20 mM FP or HF for 48, 72 and 96 h
Figure 7. Electrospray ionization mass spectrum of CaM-Ca
2+ with FP. The solution was prepared by mixing equal volumes of a 0.4 mM
methanol solution of FP and 0.04 mM CaM-Ca
2+.NMultiply-charged ion peaks of CaM-Ca
2+;N# multiply-charged ion peaks of CaM-Ca
2+-FP complex.
doi:10.1371/journal.pone.0036652.g007
Figure 8. Effect of PE on fluorescence spectra in different protein solutions. A) Effect of FP on fluorescence spectra of CaM. B) Effect of FP
on fluorescence spectra of PDE; C) Enhanced fluorescence spectra of CaM and PDE in presence of Ca
2+. D) Effect of FP on fluorescence spectra of
CaM-Ca
2+-PDE at 37uC. E) Effect of FP on fluorescence spectra of CaM-Ca
2+-PDE at 25uC.
doi:10.1371/journal.pone.0036652.g008
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uptake for 72 h, which represents a later stage of apoptosis. Thus,
although both FP and HF could induce HeLa cell apoptosis, FP
was more potent than HF in terms of activating apoptosis,
indicating that FP may represent a potential anticancer agent for
use in human cervical cancer therapy. Cell growth is controlled by
the balance between proliferation and programmed cell death
(apoptosis). In order to further understand the molecular
mechanisms responsible for the anticancer activities of HF and
FP, the expression levels p21/Waf1, PCNA and apoptosis-related
proteins were examined.
p21/Waf1 inhibits CDK activities and prevents cell cycle
progression [18,19]. The development of sporadic tumors is
generally associated with reduced expression of p21/Waf1 [20].
Moreover, increased expression of p21/Waf1 has been demon-
strated to inhibit proliferation and promote apoptosis of malignant
cells in vitro and in vivo [21,22]. PCNA is markedly expressed in
proliferating cells and in most malignant tumor cells, and is
therefore used as a proliferative/malignancy biomarker in cancer
[23,24]. Cleaved caspase-3 has been verified as an activated form
of caspase-3 that acts as a lethal protease at the most distal stage of
the apoptotic pathway [25]. At the onset of apoptosis, caspase-3
proteolytically cleaves PARP, which is a nuclear DNA-binding
zinc-finger protein that influences DNA repair, DNA replication,
modulation of chromatin structure, and apoptosis [26].
We investigated the involvements of p21/Waf1 and PCNA
proteins in the antiproliferative effects of HF- and FP in HeLa
cells. FP induced cell cycle arrest in both G0/G1 and G2/M
phases as shown by up-regulation of p21 and down-regulation of
PCNA in HeLa cells. Enhanced expression of cleaved caspase-3
and PARP-1 (90 kD) in FP- or HF-treated HeLa cells at 48 h
provided further evidence for promotion of apoptosis by FP and
HF. However, the levels of cleaved PARP-1 were lower than those
of cleaved caspase-3 after FP and HF treatment, indicating that
activated caspase-3 may activate other downstream caspase family
effectors. FP is characterized by the presence of a 7-hydroxy-
flavone basic ring skeleton, with an extra phosphate ester
substitution. This structural difference is related to its mechanism
of action and potency. Together, FP-induced apoptosis and
proliferation inhibition contribute directly to up-regulation of
p21/Waf1, decreased PCNA, and increased cleavage of caspase-3
and PARP-1. In contrast, 7-hydroxyflavones lacking this phos-
phate ester substitution mediated cell cycle arrest in G0/G1 phase
and showed antiproliferative activity consistent with inhibition of
PCNA activity. The induction of p21/Waf1 by HF might be
responsible for cell-cycle arrest but not apoptosis (elevated p21 vs.
no obvious apoptosis for HF at 48 h). These results suggest that FP
and HF might induce growth inhibition and apoptosis by different
mechanisms.
cAMP signaling pathways are known to provide major routes
for controlling cellular function [27,28]. In an in vitro experiment,
cAMP was considered to exert a growth-inhibitory action on
SKOV cells via induction of p21 expression and cell cycle arrest,
with accumulation of cells in the G0/G1 fraction of the cell cycle
[29]. In the present study, the FP-mediated activation of p21/
Waf1 in Hela cells elicited a profound increase in cAMP
concentrations, which appear to inhibit cell growth through
induction of p21 expression and inhibition of PCNA and cell cycle
progression in G1 or G2/M. cAMP inactivation is known to occur
through hydrolysis to 59-AMP, which is achieved by cAMP PDE
activity [30,31]. Within the PDE enzyme family, PDE1 activities
are stimulated by Ca
2+ and CaM, and can specifically control
cAMP degradation within the cell regulatory system. In addition,
these isoenzymes may be inhibited by several flavonoids [32]. As
previously reported for a number of non-selective PDE inhibitors,
the current results showed that FP preferentially inhibited CaM-
activated PDE1 (which hydrolyzes cAMP) isolated from bovine
brain, with an IC50 value of 22.3 mM, which was significantly
lower than the IC50 (43.5 mM) necessary for inhibition of basal
PDE, indicating that FP also interacts with CaM. Both HF and FP
may thus act as PDE inhibitors with different activities, resulting in
increased levels of cyclic nucleotides. It is thus likely that the effect
of FP on p21 regulation may be associated with an increase in
intracellular cyclic nucleotide levels (via PDE inhibition). FP
showed greater potency than HF in most of the current
experiments, indicating that the presence of a phosphate ester in
the chemical structure of FP (7-position) increases its pharmaco-
logical activity by producing a spatial conformation that favors
interaction with PDE and other potential cellular targets.
Comprehensive studies on the nature of the interactions
between small molecules and proteins are of fundamental
importance in the biomedical and pharmaceutical sciences. In
this context, we extended the scope of this study to examine the
interaction between FP and CaM-Ca
2+-PDE1 using fluorescence
spectrometry combined with ESI-MS. A new noncovalent
complex (FP-CaM-Ca
2+) analyzed by ESI-MS further verified
Figure 9. Calculation of binding constants. A) Stern-Volmer plots of FP and CaM-Ca
2+-PDE system at different temperature (25uC and 37uC). B)
Line weaver-Burk plots of FP versus CaM-Ca
2+-PDE at 25uC and 37uC; k25uC=6.24610
4 M
21 and k37uC=4.8610
4 M
21, K represents binding constant.
doi:10.1371/journal.pone.0036652.g009
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2+, compared to
HF. Furthermore, the FP-CaM-Ca
2+ noncovalent complex was
likely to influence PDE1 species activities via specific CaM-Ca
2+
stimulation. The fluorescence intensity of a mixed solution of
CaM-Ca
2+ and PDE in vitro was also significantly elevated
compared to either CaM-Ca
2+ or PDE1 alone, confirming that
specific induction by Ca
2+/CaM stimulated PDE1 activity. The
effects of FP on the emission spectra of the CaM-Ca
2+-PDE
protein-enzyme complex system demonstrated an enhanced
molecular interaction between FP and the CaM-Ca
2+-PDE
enzyme complex system.
Determination of the FP and CaM-Ca
2+-PDE1 binding
constants provided information on the binding sites and the main
acting forces in the studied complexes. The binding effects
detected by fluorescence and ESI-MS assays were in agreement
with the results of PDE activity, despite the different principles of
the methods. The results obtained could facilitate our understand-
ing of the physiological effects by focusing on the structural
features. Our previous study showed that the individual biological
potency of the phosphate ester of chrysin was related at least partly
to its phosporylated structure [11]. Phosphorylated flavones might
thus combine with the active site of PDEs by H-bond interactions,
preventing the CaM-Ca
2+-PDE enzyme complex from effectively
hydrolyzing cAMP.
To summarize, this study demonstrated that FP has clear
anticancer effects in Hela cells, probably mediated by an increase
in cytosolic cAMP via inhibition of PDE. FP exerts growth
inhibitory and apoptosis-inducing actions through induction of
p21, caspase-3 and PARP-1, and down-regulation of PCNA
associated with cell cycle arrest. In contrast, HF has lower activity
against HeLa tumor cells under the same conditions. These
observations clearly demonstrate the importance of phosphorylat-
ed flavonoids in biological processes, and suggest that FP might
have promising potential as a new anti-cancer drug.
Materials and Methods
Test compounds
HF (7-Hydroxy-flavone, C15H10O3,Mr: 238.24) was purchased
from Sigma (St. Louis, MO, USA), and FP was synthesized by a
simplified Atheron-Todd reaction (Figure 10).
MTS assay
The test compounds (HF and FP) were dissolved in dimethyl
sulfoxide (DMSO) #0.1%. HeLa cells (human cervical carcinoma,
Shanghai Institutes of Biological Sciences) were cultured in
DMEM (Gibco, Invitrogen, USA) supplemented with 10% fetal
bovine serum (Gibco). Cell viability was measured in the presence
or absence of HF or FP using a cell viability assay, as previously
described [33]. The cells were harvested in the log phase of growth
and inoculated onto 96-well plates at a final concentration of
3610
3 cells per well. After 24 h of incubation at 37uC under 5%
CO2, the cell cultures were treated with FP/HF at 5, 10, 20, 40, 80
and 160 mM. [3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxy-
phenyl)-2(4-sulfophenyl)-2H-tetrazolium/phenazine methosulfate
(MTS/PMS; Promega, Madison, WI, USA) 20 ml was added to
each well, and the absorbance at 490 nm was measured according
to the manufacturer’s recommendations. The mean value was
obtained from four replicate wells after exposure to the agents for
24, 48, 72 and 96 h, respectively. A control group treated with no
any agents was performed simultaneously. The growth inhibition
ratio was calculated according to the following equation: inhibition
ratio (%)=(control group2treated group)/control group6100%.
Preparation of specimens
20 mM HF and FP were added to HeLa cell cultures for 24, 48
and 72 h. TUNEL, PCNA immunocytochemistry tests and
western blotting (p21/Waf1, caspase-3 and PARP1) were
performed, based on the above MTS assay. Experimental and
control specimens for TUNEL and immunocytochemistry assays
were fixed on slides with 4% paraformaldehyde for 20 min at
room temperature, followed by washing in phosphate-buffered
saline (PBS), and storage at 220uC.
Cell-cycle analysis
HeLa cells were seeded at a density of 1610
5 onto 6-well plates
and incubated for 24, 48, 72 and 96 h in the absence or presence
of the test compounds (10, 20, 40 and 80 mM concentrations after
reaching 70% confluency. The cells were washed twice with PBS,
then harvested by trypsinization and washed twice with PBS.
Then pellets were resuspended and fixed in 70% alcohol for 1 h at
4uC. The suspension was then centrifuged in a microfuge for
5 min at 800 rpm, and the pellet was resuspended in PBS
containing PI (50 mg/ml), Triton X-100 (0.1%, v/v) and RNase A
(100 mg/ml). After 30 min incubation, the cell cycle distribution
was examined using a FACScano II SE flow cytometer with
Modfit software (Becton Dickinson, San Jose, CA).
TUNEL method for detection of apoptosis
TUNEL analysis to detect apoptosis was performed as described
previously, with 1 ml terminal dUTP-transferase (TdT, Promega,
Madison, WI, USA) and 1 ml biotin-16-dUTP (Promega) [11].
Positive bluish-violet signals were visualized using streptavidin-
alkaline phosphatase reaction with 5-bromo-4-chloro-3-indolyl-
phosphate and nitroblue tetrazolium (BCIP-NBT, Promega) as the
substrate. TdT was omitted from the buffer in the negative control
specimen. The percentage of apoptosis (% of apoptosis) according
to the positive signal was calculated for each slide, in which ten
fields of view were selected under an oil-emersion microscope
(Nikon, TE2000-U, Japan). Apoptosis (%)=(number of apoptosis
cells/total number of tumor cells)6100.
Figure 10. Scheme of diethyl flavon7-yl phosphate (FP) synthesized by a simplified Atheron-Todd reaction.
doi:10.1371/journal.pone.0036652.g010
Inhibition Effect and Mechanism of FP in HeLa Cell
PLoS ONE | www.plosone.org 10 May 2012 | Volume 7 | Issue 5 | e36652Annexin V-FITC/PI double staining for apoptosis by flow
cytometry
HeLa cells were seeded at a density of 5610
5 onto 6-well plates
and incubated for 24, 48, 72 and 96 h in the presence or absence
of the test compounds (10, 20, 40 and 80 mM). Apoptosis assay was
performed with an Apoptosis Assay Kit (Baosai Biology, Beijing,
China) using a flow cytometer, following the manufacturer’s
instructions. Briefly, cells were trypsinized and washed with PBS.
The pellets were resuspended in PBS to a concentration of 5610
5
cells. The cells were then incubated with 10 ml FITC-Annexin-V
dissolved in 300 ml binding buffer in the dark at room temperature
for 15 min. The pellets were stained with 5 ml PI in 200 ml binding
buffer. Emission wavelengths of 518 nm (Annexin V-FITC) and
617 nm (PI) were used to identify the populations of viable cells
(Annexin V
2PI
2), early apoptotic cells (Annexin V
+PI
2), necrotic
cells (Annexin V
2PI
+), and late apoptotic cells (Annexin V
+PI
+).
The collected events per sample were 10,000. Apoptotic percent-
age (AP %)=(upper right quadrant (UR)+lower right quadrant
(LR)) %.
Immunocytochemistry
Paraformaldehyde-fixed slides were treated with 0.5% Triton
X-100/PBS solution for 30 min followed by 3% H2O2 for 5 min.
The slides were heat-renatured in 0.05 mM citric acid buffer
(pH 6.0 for antigen retrieval), and blocked with 1:10 diluted
normal goat serum in PBS for 30 min. After removal of excess
serum, slides were incubated overnight at 4uC with monoclonal
antibody against PCNA (Zymed, Invitrogen, USA) freshly diluted
at 1:100, followed by incubation with biotin-labeled goat anti-
mouse serum and streptavidin conjugated peroxidase at 37uC for
20 min. 3, 39diaminobenzidine 0.05% and 0.01% H2O2 were
used as substrates to develop a brownish positive IR signal. PBS
was substituted for the specific primary antibody in the negative
control. Slides were examined and 200 cells were counted in ten
different fields of view by two independent, blinded observers,
using an oil-emersion microscope. The IV of PCNA-IR was based
on a previously reported method [34,35], and modified as follows:
0=negative (2, no appreciable staining in cells); 1=weak positive
(+, readily-appreciable brown staining distinctly marking the
tumor cell cytoplasm and/or nucleus); 2=medium positive (++,
dark brown staining in tumor cells obscuring the cytoplasm and/
or nucleus); 3=strong positive (+++, very strong staining of
nucleus and/or cytoplasm). The IV of PCNA-IR was scored semi-
quantitatively by multiplying the number of positive cells (0–200)
by the staining intensity (grade 1–3), thus producing a score of 0–
600.
Western blotting analysis of caspase-3, PARP-1 and p21/
waf1 proteins in Hela cells
HeLa cells were seeded in 24-well plates (5610
4/well) and
cultured for 24 h. HF or FP 20 mM were added to the cells for a
further 24 or 48 h. Extracts from each group cells were prepared
and western immunoblotting analysis was performed as follows:
The cells were washed twice with PBS, scraped from the culture
dishes, and treated for 20 min on ice with lysis buffer containing
1 mM EGTA, 1 mM EDTA, 150 mM NaCl, 1% Triton X-100,
2.5 mM sodium pyrophosphate, 1 mM phenylmethyl-sulfonyl
fluoride, 1 mM NaVO4 and 1 mg/ml leupeptin, 1 mg/ml
aprotinin and 20 mM HEPES-KOH (pH 7.9). Cell lysates were
centrifuged at 13,000 rpm for 15 min at 4uC. Total protein
concentrations were determined and equal amounts of proteins in
each group were then separated by 12% sodium dodecyl sulfate-
polyacrylamide gel electrophoresis. The gels were transferred to a
nitrocellulose membrane (Amersham, GE Heathcare, USA) using
a semi-dry electroblotting system (Bio-Rad, USA). The mem-
branes were blocked with 3% (w/v) bovine serum albumin in PBS
with 0.2% (v/v) Tween-20 (PBST) for 1 h, and then incubated
with the primary mouse monoclonal antibody (anti-caspase3 and
anti-PARP-1, Santa Cruz Biotechnology, Santa Cruz, CA, USA,
1:200), mouse monoclonal antibody (against p21
Waf1, Santa Cruz,
1:200), and b-actin monoclonal antibodies (1:1,000; Santa Cruz) at
4uC overnight with rocking. Membranes were rinsed three times
with PBST, and incubated with secondary goat anti-mouse IgG
conjugated with IRDye700 fluorescence in (1:10,000 dilution; LI-
COR, USA) for 1 h at room temperature. Membranes were rinsed
twice with PBST and once with PBS. Subsequent analysis was
performed using a Li-COR Odyssey system and quantified using
Odyssey infrared imaging software, with b-actin as a loading
control.
RIA examination of cAMP in cells
HeLa cells were seeded at a density of 3610
4 onto 24-well plates
and incubated for 12 or 24 h in the presence or absence of the test
compounds (20 mM). Cells were washed three times with PBS and
then freeze-thawed twice with 0.5 ml cold HCl (50 mM) at
280uC. Cell lysates were centrifuged at 13,000 g for 10 min at
4uC. The supernatants were freeze-dried and stored at 280uC.
The cAMP concentration of each sample was measured using
commercial RIA kits (Shanghai University of Traditional Chinese
Medicine, Shanghai, China). The minimum detection limit for
cAMP was 0.1 pmol/ml for nonacetylated samples; cross-reaction
with cGMP was less than 0.001%. In brief, duplicate aliquots of
samples (100 ml) and 100 ml of each point of cAMP standard curve
(20,10, 5, 2.5, and 1.25 pmol/ml) were dispensed into conical
tubes containing 100 ml of assay buffer, then incubated with 100 ml
of
125I-cAMP (25,000 cpm) and 100 ml of diluted primary
antibody (rabbit anti-cAMP). The initial dilution of the antiserum
was 1:500. The maximum binding (B0) was determined by
replacing standard cAMP by 100 ml of assay buffer. The
nonspecific binding (NSB) tubes contained 200 ml of assay buffer
and 100 mlo f
125I-cAMP. Total count tubes (Tc) contained 100 ml
of
125I-cAMP. The following day, bound and free fractions were
separated by adding 100 ml of second-antibody solution (0.05% v:v
normal rabbit serum, 0.45% v:v sheep anti-rabbit anti serum,0.4%
w:v BSA, 0.05% w:v microcrystalline cellulose, 0.5%w:v polyeth-
ylene glycol 6000 in phosphate buffer) to all except the Tc tubes,
followed by further incubation (1.5 h) at room temperature. The
tubes were then washed with 2 ml of phosphate-BSA-Tween 20
TM
buffer and centrifuged at 2,500 g at 4uC for 30 min. The
supernatant was discarded and the pellet was washed again. The
radioactivity was measured in a gamma counter with an efficiency
of 75%.
Determination of PDE activity
PDE activity was measured using the PDE-Glo
TM Assay
(Promega, Madison, WI, USA), according to the manufacturer’s
instructions. HF and FP were serially titrated manually at 1:2, and
added to the assay plate containing bovine brain PDE (Sigma-
Aldrich Cat.# P9529) or CaM-activated PDE, in which 2 U CaM
(Sigma-Aldrich Cat.# P4874) were incubated with 0.015 U PDE
and 0.03 mM Ca
2+ for 30 min, and pre-incubated for 5 min
before substrate addition. cAMP substrate 2 mM was added to
each well for 5 min. Luminescence was recorded using a
GloMaxH-Multi Microplate Reader (Promega). Value was ex-
pressed as a relative light units (RLU). The IC50 values were
determined by non-linear regression analysis by fitting to
hyperbolic inhibition. The maximal final concentration of DMSO
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the limited solubility of the tested flavonoids, the highest
concentration used in these experiments was 200 mM.
Mass spectrometry conditions
A mass spectrometer (Bruker-Esquire 3000 Ion Trap, Bruker
Daltonics, Bermen, Germany) installed with an ion-spray source
working in the positive ion mode was employed. The neutralizer
pressure was 12 psi, the dry gas flow rate was 9.00 l/min, and the
capillary voltage was held at 4 kV. The rolling average was seven.
The ion count cumulative (ICC) was set at 30,000. Dissolved
samples were continuously infused into the ESI chamber at a flow
rate of 4 ml/min using a 744900 syringe pump (Cole-Parmer
Instrument Co., USA).
Fluorescence spectra
The binding reactions between FP and Ca
2+-CaM-PDE
enzyme system in the aqueous phase were studied using
fluorescence spectrometry. Fluorescence spectra were detected
using a F4500 spectrofluorometer with an excitation wavelength of
280 nm and an emission range set between 290 nm and 450 nm.
The excitation wavelength for proteins is generally about 280 nm,
and this wavelength was therefore selected to study the FP and
Ca
2+-CaM-PDE enzyme system interaction. No fluorescence was
emitted by FP under this excitation wavelength. The quenching
experiments were repeated with different quantities of FP at 25uC
and 37uC, for the same Ca
2+-CaM-PDE enzyme concentration.
Statistical analysis
At least three independent experiments were carried out for
each variable. Data are given as mean 6 SE. The statistical
analysis was made with SSPS10.0. Differences (p,0.05), indicated
by asterisks, were considered statistically significant.
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